Halozyme Therapeutics shares owned by Axiom International Investors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Axiom International Investors
from 13F filings
Historical chart of Axiom International Investors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Axiom International Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Axiom International Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.2M | 32k | 38.20 |
| 2023-06-30 | $976k | 27k | 36.07 |
| 2023-03-31 | $1.6M | 41k | 38.19 |
| 2022-12-31 | $6.4M | 112k | 56.90 |
| 2022-09-30 | $4.5M | 113k | 39.54 |
| 2022-06-30 | $3.8M | 87k | 44.00 |
| 2022-03-31 | $2.6M | 65k | 39.89 |
| 2021-12-31 | $3.3M | 82k | 40.21 |
| 2021-09-30 | $3.9M | 96k | 40.68 |
| 2021-06-30 | $4.9M | 107k | 45.41 |
| 2021-03-31 | $4.3M | 103k | 41.69 |
| 2020-12-31 | $5.6M | 131k | 42.71 |
More positions owned by Axiom International Investors
View all positions for Axiom International Investors